There were 69 cases of p53 wildtype breast cancer that had a similar expression of p21 to p21–low p53 mutated/deep deleted cancers, suggesting that these cancers could have compromised p53 function (Figure S3). This evidence concerns the gene CDKN1A and breast cancer.